W7V.F WELL HEALTH TECHS
- Market cap
- EUR 596M
- P/E
- -
- P/B
- 1.20x
- ROE
- -25.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is W7V.F undervalued?
Graham numberThe Graham number of WELL HEALTH TECHS cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
WELL HEALTH TECHS fundamental analysis
No fundamental analysis for WELL HEALTH TECHS yet.
WELL HEALTH TECHS stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About WELL HEALTH TECHS
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. The company offers omni-channel patient services and solutions to specific markets, such as medical recruitment and staffing, anesthesia, gastrointestinal health, women's health, primary care, and behavioural health. It also develops, integrates, and sells its own suite of technology software and technology solutions to medical clini…
Full company profileWELL HEALTH TECHS financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
WELL HEALTH TECHS annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 302M | 569M | 776M | 920M | 1.40B | 1.57B |
| Gross Profit | 154M | 303M | 372M | 363M | 619M | 693M |
| Operating Income | -8.54M | 24.0M | 34.5M | -30.8M | 92.7M | 57.4M |
| EBITDA | - | 97.5M | 113M | 118M | 156M | 41.8M |
| Net Income | -44.2M | 1.37M | 82.0K | 32.6M | -7.36M | -202M |
| EPS | -0.21 | 0.01 | 0.00 | 0.13 | -0.03 | -0.79 |
| Balance Sheet | ||||||
| Total Assets | 1.29B | 1.32B | 1.41B | 1.81B | 2.10B | 2.35B |
| Total Liabilities | 580M | 504M | 563M | 878M | 1.06B | 1.31B |
| Shareholders' Equity | 618M | 732M | 768M | 868M | 864M | 798M |
| Cash & Short-term Investments | 61.9M | 48.9M | 43.4M | 132M | 134M | 199M |
| Cash Flow | ||||||
| Operating Cash Flow | 22.3M | 76.5M | 66.4M | 9.52M | 122M | 90.7M |
| Capital Expenditure | 2.68M | 6.40M | 8.11M | 16.2M | 27.9M | 43.0M |
| Free Cash Flow | 19.6M | 70.1M | 58.3M | -6.70M | 94.0M | 47.7M |
| Ratios | ||||||
| ROE | -7.2% | 0.2% | 0.0% | 3.8% | -0.9% | -25.3% |
| ROA | -3.4% | 0.1% | 0.0% | 1.8% | -0.4% | -8.6% |
| Net Profit Margin | -14.6% | 0.2% | 0.0% | 3.5% | -0.5% | -12.9% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
WELL HEALTH TECHS dividends
WELL HEALTH TECHS has not paid dividends in the last 5 fiscal years.
Who owns WELL HEALTH TECHS
- Insiders 20.77%
- Institutions 7.81%
- Public & others 71.42%
- Shares outstanding 257M
- Free float 235M
WELL HEALTH TECHS company profile
- Company name
- WELL HEALTH TECHS
- Ticker
- W7V.F
- ISIN
- CA94947L1022
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Fiscal year end
- December
- Address
- 375 Water Street, Vancouver, BC, Canada, V6B 5C6
- Phone
- 604-628-7266
- Website
- well.company
About WELL HEALTH TECHS
WELL Health Technologies Corp. operates as a practitioner-focused digital healthcare company in Canada, the United States, and internationally. The company offers omni-channel patient services and solutions to specific markets, such as medical recruitment and staffing, anesthesia, gastrointestinal health, women's health, primary care, and behavioural health. It also develops, integrates, and sells its own suite of technology software and technology solutions to medical clinics and healthcare practitioners. In addition, the company operates practitioner enablement platform, including Electronic Medical Records (EMR); telehealth platforms; practice management; AI-powered virtual assistant (WELL AI Voice); billing and revenue cycle management solutions, such as DoctorCare, ClinicAid, and PatientServ; OceanMD, an EMR-integrated patient engagement solutions; and cybersecurity protection and patient data privacy solutions, as well as OSCAR Pro, AwareMD, and Healthquest EMR systems. WELL Health Technologies Corp. was founded in 2010 and is headquartered in Vancouver, Canada.
WELL HEALTH TECHS management
10- Mr. Hamed Shahbazi B.Sc.Founder, Chairman & CEO · born 1975
- Mr. Bill CrawfordChief Financial Officer of CRH
- Ms. Dina SergiChief Executive Officer of WELL Diagnostic Centres
- Ms. Evelyn Louise Sutherland C.A., C.P.A., FCPAChief Financial Officer · born 1974
- Mr. Derek ClarkChief Operating Officer
- Mr. Ric Leong B.Sc., C.A., C.P.A.Chief Accounting Officer
- Mr. Kaytek PrzybylskiChief Digital & Information Officer
- Mr. Pardeep S. Sangha M.B.A.VP of Corporate Strategy & Investor Relations
- Mr. Loreto Grimaldi B.B.A., J.D., M.B.A.Chief Legal Officer · born 1971
- Mr. Chris EricksenSenior VP of Strategic Partnerships & Marketing